HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PentaLyte decreases lung injury after aortic occlusion-reperfusion.

Abstract
Lung injury often occurs after hepatoenteric ischemia, with xanthine oxidase (XO, an oxidant-generating enzyme), released from reperfusing liver and intestines, mediating a significant component of this injury. Since pentastarch administration decreases intestinal reperfusion injury, we determined whether resuscitation with PentaLyte (a pentastarch-containing solution) would decrease hepatoenteric reperfusion injury, xanthine oxidase release, and concomitant lung injury after aortic occlusion- reperfusion. Aortic occlusion was established in rabbits for 40 min, and was followed by 3 h of reperfusion, during which either PentaLyte or lactated Ringer's solution-based resuscitation was administered. Sham-operated animals served as controls. Hepatoenteric reperfusion injury, as manifested by release of the enzyme aspartate aminotransferase and decreased gastric intramucosal pH, was significantly (p < 0.0167) attenuated by PentaLyte administration after aortic occlusion-reperfusion, as compared with its occurrence in animals given lactated Ringer's solution. The release of XO after aortic occlusion-reperfusion was 4-fold smaller after PentaLyte administration than after resuscitation with lactated Ringer's solution (p < 0.05). Pulmonary injury, as defined by an increase in bronchoalveolar lavage fluid (BALF) protein content and lactate dehydrogenase (LDH) activity, was 4-fold less after PentaLyte administration following aortic occlusion-reperfusion than after administration of lactated Ringer's solution (p < 0.05). We conclude that remote pulmonary injury is significantly decreased by concomitant PentaLyte-mediated reduction of hepatoenteric reperfusion injury and XO release.
AuthorsR N Axon, M S Baird, J D Lang, A E Brix, V G Nielsen
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 157 Issue 6 Pt 1 Pg. 1982-90 (Jun 1998) ISSN: 1073-449X [Print] United States
PMID9620936 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Blood Proteins
  • Electrolytes
  • Hydroxyethyl Starch Derivatives
  • Isotonic Solutions
  • PentaLyte
  • Plasma Substitutes
  • Ringer's Lactate
  • Phenylephrine
  • Sodium Bicarbonate
  • L-Lactate Dehydrogenase
  • Xanthine Oxidase
  • Aspartate Aminotransferases
  • Glucose
Topics
  • Animals
  • Aorta, Thoracic (physiology)
  • Aspartate Aminotransferases (blood)
  • Blood Proteins (analysis)
  • Bronchoalveolar Lavage Fluid (chemistry)
  • Constriction
  • Electrolytes (administration & dosage)
  • Gastric Mucosa (metabolism)
  • Glucose (administration & dosage)
  • Hydrogen-Ion Concentration
  • Hydroxyethyl Starch Derivatives (administration & dosage)
  • Infusions, Intravenous
  • Intestines (blood supply)
  • Isotonic Solutions (administration & dosage)
  • L-Lactate Dehydrogenase (blood)
  • Liver (blood supply)
  • Male
  • Phenylephrine (administration & dosage)
  • Plasma Substitutes (administration & dosage)
  • Rabbits
  • Reperfusion Injury (complications, metabolism, therapy)
  • Respiratory Distress Syndrome (etiology, prevention & control)
  • Resuscitation
  • Ringer's Lactate
  • Sodium Bicarbonate (administration & dosage)
  • Xanthine Oxidase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: